Replicel Life Sciences Inc REPCF:OTCPK

RT Quote | Exchange | USD
Last | 05/13/22 EDT
0.0952UNCH (UNCH)
52 week range
0.10 - 0.34
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0952
  • 52 Week High0.34
  • 52 Week High Date06/01/21
  • 52 Week Low0.10
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap3.35M
  • Shares Out36.16M
  • 10 Day Average Volume7,435.2
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-47.49

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0952
  • 52 Week High0.34
  • 52 Week High Date06/01/21
  • 52 Week Low0.10
  • 52 Week Low Date05/12/22
  • Market Cap3.35M
  • Shares Out36.16M
  • 10 Day Average Volume7,435.2
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-47.49

RATIOS/PROFITABILITY

  • EPS (TTM)-0.09
  • P/E (TTM)-1.04
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Replicel Life Sciences Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
RepliCel Life Sciences Inc. is a regenerative medicine company. It is focused on developing autologous cell therapies that treat functional cellular deficits including chronic tendon injuries, androgenetic alopecia, and skin aging. Its product pipeline includes RCT-01 for Tendon Repair, RCS-01 for Skin Rejuvenation, RCH-01 Hair Growth and RCI-02 Dermal Injector Publication . RCT-01 is an autologous cell-based treatment utilizing non-bulbar dermal sheath cells isolated from...
David Hall
Independent Chairman of the Board
R. Lee Buckler
President, Chief Executive Officer, Corporate Secretary, Director
Simon Ma
Chief Financial Officer
Address
570 Granville St Suite 900
Vancouver, BC
V6C 3P1
Canada